XETRA:HPHA
Heidelberg Pharma AG
- Stock
locale
Germanymarket
STOCKSindustry
Biotechnologywebsite
heidelberg-pharma.comipo date
Nov 13, 2006
Heidelberg Pharma AG, a biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, other European countries, the United States, and internationally. Its lead product candidate is HDP-101, which in the Phase I/IIa study for the treatment of relapsed or refractory multiple myeloma. It is developing HDP-102 for the treatment of non-...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus